Director, US Scientific Marketing – Melanoma

Iovance Biotherapeutics(1 month ago)

HybridFull TimeDirector$222,775 - $294,154 (estimated)Marketing (Cell Therapy)

About this role

The Director of Scientific Marketing, Melanoma will set the scientific strategy and medical education direction for AMTAGVI, the FDA-approved T cell therapy for metastatic melanoma, within Iovance’s US Cell Therapy Marketing team. The role focuses on advancing the Advanced Melanoma market and will expand to support additional indications as pipeline programs mature. This senior position requires an entrepreneurial mindset and reports to the Head of Marketing, contributing to the first-in-class launch and commercialization efforts.

View Original Listing

Required Skills

Scientific Marketing
Medical Education
P2P Strategy
Content Development
Speaker Programs
Program Execution
Strategic Thinking
Analytical Thinking
Regulatory Compliance
Cross-Functional Collaboration

+7 more

Qualifications

Bachelor's Degree in Marketing or Related Field
MD
PharmD
PhD
MBA

About Iovance Biotherapeutics

iovance.com

Iovance Biotherapeutics is a clinical-stage biopharmaceutical company developing tumor-infiltrating lymphocyte (TIL) therapies that harness a patient’s own immune cells to recognize and kill diverse cancer cells. Its lead product, AMTAGVI (lifileucel), has received U.S. FDA accelerated approval for defined indications, and the company is advancing multiple clinical trials across solid tumors. Iovance builds and operates cell therapy manufacturing and Iovance Cell Therapy Centers to support production and commercialization, and partners with academic and industry collaborators to advance next‑generation T‑cell platforms. The company also provides patient resources, an expanded-access policy, and information about its pipeline and research.